Elanco Animal Health Inc (ELAN)
14.04
-0.15
(-1.06%)
USD |
NYSE |
Nov 14, 16:00
14.04
0.00 (0.00%)
After-Hours: 20:00
Elanco Animal Health Shareholders Equity (Quarterly): 6.523B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 6.523B |
June 30, 2024 | 5.942B |
March 31, 2024 | 6.056B |
December 31, 2023 | 6.223B |
September 30, 2023 | 6.134B |
June 30, 2023 | 7.42B |
March 31, 2023 | 7.48B |
December 31, 2022 | 7.289B |
September 30, 2022 | 6.745B |
June 30, 2022 | 7.14B |
March 31, 2022 | 7.612B |
December 31, 2021 | 7.508B |
September 30, 2021 | 7.682B |
June 30, 2021 | 7.98B |
Date | Value |
---|---|
March 31, 2021 | 8.007B |
December 31, 2020 | 8.476B |
September 30, 2020 | 8.344B |
June 30, 2020 | 6.652B |
March 31, 2020 | 6.662B |
December 31, 2019 | 5.547B |
September 30, 2019 | 5.488B |
June 30, 2019 | 5.266B |
March 31, 2019 | 5.196B |
December 31, 2018 | 5.198B |
September 30, 2018 | 5.137B |
June 30, 2018 | 7.587B |
December 31, 2017 | 7.780B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.547B
Minimum
Dec 2019
8.476B
Maximum
Dec 2020
7.071B
Average
7.214B
Median
Shareholders Equity (Quarterly) Benchmarks
Baxter International Inc | 7.643B |
Edwards Lifesciences Corp | 9.546B |
Syros Pharmaceuticals Inc | -11.12M |
Opus Genetics Inc | 40.64M |
Edgewise Therapeutics Inc | 510.47M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.28B |
Total Liabilities (Quarterly) | 6.76B |
Debt to Equity Ratio | 0.6679 |
Current Ratio | 2.548 |
Net Debt Paydown Yield | 4.70% |